Investor's Business Daily on MSN16h
AstraZeneca Could Pay $4.5 Million In China Scandal. Here's Why Shares Jumped.AstraZeneca stock rose early Thursday after the drugmaker beat fourth-quarter earnings views and delivered upbeat guidance.
Pharmaceutical Technology on MSN16h
AstraZeneca’s shares rise as it addresses China investigationIn addition to the UK investment controversy, AstraZeneca is also dealing with legal challenges in China. The company ...
AstraZeneca on Thursday warned that it could be fined millions of dollars in importation tax fines as Chinese authorities ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...
A pharma industry group asked the FDA to "take action" against a "dangerous" ad Hims & Hers plans to run during the Super Bowl ...
The FTSE 100 finished up 103.99 at 8727.28 - a new record closing high. It also hit a new intraday record of 8,767.50 earlier ...
Zacks.com on MSN21h
AZN Q4 Earnings Lag, Sales Beat, Stock Up on China Probe UpdateAstraZeneca’s AZN fourth-quarter 2024 core earnings of $1.05 per American depositary share (“ADS”) missed the Zacks Consensus ...
The Monetary Policy Committee, which consists of three RBI and three external members, cut the repo rate by 25 basis points, ...
Footwear News on MSN15h
Skechers Posts Record Sales in 2024, But Misses ForecastThe company reported net sales of $8.97 billion in fiscal 2024, a 12.1 percent increase from $8.0 billion in prior year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback